论文部分内容阅读
用抗乙型肝炎（下称乙肝）免疫核糖核酸治疗慢性乙肝３５例（男性２３例，女性１２例；年龄４４．０±ｓ２．２ａ），剂量３ｍｇ，ｉｍ、ｑｏｄ连用１ｍｏ，后改为３ｍｇ，ｉｍ，ｂｉｗ连用２ｍｏ，并与灭澳灵治疗５９例（剂量３片，ｔｉｄ连用３ｍｏ）作比较。结果：２组总有效率分别为９１％与８８％，无显著性差异（Ｐ＞０．０５）；ＨＢｓＡｇ，ＨＢｅＡｇ和抗ＨＢｃ阴转率各为３８％，１４％，６５％和４０％，５５％，２７％、２组比较差异显著（Ｐ＜０．０５）。
Thirty-five cases of chronic hepatitis B (23 males and 12 females; age 44.0 ± s2.2a) were treated with anti-hepatitis B (hereinafter referred to as hepatitis B) , Im, biw used 2mo, and the treatment of omeprazole 59 cases (dose 3, tid use 3mo) for comparison. Results: The total effective rates of the two groups were 91% and 88% respectively, with no significant difference (P> 0.05). The negative conversion rates of HBsAg, HBeAg and anti HBc were 38%, 14%, 65% and 40% 55% and 27% respectively. There was significant difference between the two groups (P <0.05).